ULTROMICS LIMITED

Active Oxford

Other human health activities

73 employees website.com
Life sciences and medical technology Other human health activities
U

ULTROMICS LIMITED

Other human health activities

Founded 22 Mar 2017 Active Oxford, United Kingdom 73 employees website.com
Life sciences and medical technology Other human health activities
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 20 Feb 2026 Next due 27 Dec 2026 6 months remaining
Net assets £-17M £15M 2024 year on year
Total assets £8M £6M 2024 year on year
Total Liabilities £24M £9M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

4630 Kingsgate Cascade Way Oxford Business Park South Oxford Oxfordshire OX4 2SU United Kingdom

Website

www.example.com

Full company profile for ULTROMICS LIMITED (10684811), an active life sciences and medical technology company based in Oxford, United Kingdom. Incorporated 22 Mar 2017. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2021–2024)

Cash in Bank

£5.86M

Decreased by £6.02M (-51%)

Net Assets

-£16.83M

Decreased by £15.44M (-1112%)

Total Liabilities

£24.43M

Increased by £9.37M (+62%)

Turnover

£1.53M

Increased by £176.65k (+13%)

Employees

73

Decreased by 2 (-3%)

Debt Ratio

321%

Increased by 211 (+192%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1May 2018Series A, Series B
Investor 3Aug 2021Series B
Investor 4Aug 2021Series B

Share Capital

Share Capital

Share allotments and capital structure

40 Allotments 4,394,694 Shares £75.54m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Nov 2025134,203£2.95m£21.995
23 Oct 2025400£4k£9.95
22 Oct 202516,775£369k£21.995
25 Sept 202550,326£1.11m£21.995
9 Jul 202511,239£247k£21.995

Officers

Officers

1 active 2 resigned
Status
Upton, Ross, DrDirectorBritishEngland3618 May 2017Active

Shareholders

Shareholders (77)

Oxford Science Enterprises Holdings Limited
11.1%
422,168
Oxford Science Enterprises Holdings Limited
9.9%
375,288

Persons with Significant Control

Persons with Significant Control (0)

0 Active 5 Ceased
Ceased

Paul Leeson

Ceased 18 May 2017

Ceased

Ross Upton

Ceased 18 May 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
23 Apr 2026OfficersAppointment of Mr Christopher John Percival Hopkins as director on 17 Apr 2026
22 Apr 2026OfficersTermination of Nicole Lai as director on 17 Apr 2026
20 Feb 2026Confirmation StatementConfirmation statement made on 13 Dec 2025 with updates
16 Dec 2025CapitalAllotment of shares (GBP 380.8438) on 26 Nov 2025
24 Oct 2025CapitalAllotment of shares (GBP 367.4235) on 23 Oct 2025
23 Apr 2026 Officers

Appointment of Mr Christopher John Percival Hopkins as director on 17 Apr 2026

22 Apr 2026 Officers

Termination of Nicole Lai as director on 17 Apr 2026

20 Feb 2026 Confirmation Statement

Confirmation statement made on 13 Dec 2025 with updates

16 Dec 2025 Capital

Allotment of shares (GBP 380.8438) on 26 Nov 2025

24 Oct 2025 Capital

Allotment of shares (GBP 367.4235) on 23 Oct 2025

Recent Activity

Latest Activity

Appointment of Mr Christopher John Percival Hopkins as director on 17 Apr 2026

1 months ago on 23 Apr 2026

Termination of Nicole Lai as director on 17 Apr 2026

1 months ago on 22 Apr 2026

Confirmation statement made on 13 Dec 2025 with updates

3 months ago on 20 Feb 2026

Allotment of shares (GBP 380.8438) on 26 Nov 2025

5 months ago on 16 Dec 2025

Allotment of shares (GBP 367.4235) on 23 Oct 2025

7 months ago on 24 Oct 2025